Several decades have passed since Kraepelin defined dementia praecox as a separate clinical syndrome, yet little advancement in our knowledge of its etiology has occurred. While major pharmacological treatment strategies have been established, only a diverse array of isolated multiple positive findings that give clues to its pathogenesis have emerged. Reports and hypotheses meriting further pursuit are buried within a pile of unconfirmed, often artifactual published data. Workshops for formulating and debating the merits of hypotheses for the pathogenesis and treatment of schizophrenia are far too few, despite the plethora of annual meetings devoted to psychiatric problems.
T. J. Crow and S. R. Hirsch, from the United Kingdom, have been the organizers of a unique biannual workshop addressing these issues. They assemble an international group of investigators whose methodological expertise varies widely, but whose interests remain focused on schizophrenia. The January 1984 session similarly conducted in Davos, Switzerland, was previously
DeLisi LE, Crow TJ, Hirsch SR. The Third Biannual Winter Workshop on Schizophrenia: Schladming, Austria, Jan 26-31, 1986. Arch Gen Psychiatry. 1986;43(7):706–711. doi:10.1001/archpsyc.1986.01800070096013
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: